| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.14 | 0.03 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.14 | 0.03 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | 0.077 | 0.03 |
| mRNA | lomeguatrib | CTRPv2 | pan-cancer | AAC | -0.084 | 0.03 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.063 | 0.03 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | 0.086 | 0.03 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | 0.073 | 0.03 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.14 | 0.03 |